LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Linsitinib | 0.37 | uM | LJP5 | 3 | O22 | 72 | hr | 962 | 9878 | 10315 | 0.9576 | 0.9749 |
MCF 10A | Linsitinib | 1.11 | uM | LJP5 | 1 | O21 | 72 | hr | 962 | 9335 | 10714 | 0.8713 | 0.9223 |
MCF 10A | Linsitinib | 1.11 | uM | LJP5 | 2 | O21 | 72 | hr | 962 | 9708 | 10507 | 0.9239 | 0.9546 |
MCF 10A | Linsitinib | 1.11 | uM | LJP5 | 3 | O21 | 72 | hr | 962 | 9435 | 10315 | 0.9147 | 0.9486 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 962 | 8837 | 10714 | 0.8248 | 0.8922 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 2 | O20 | 72 | hr | 962 | 9357 | 10507 | 0.8905 | 0.9339 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 3 | O20 | 72 | hr | 962 | 8998 | 10315 | 0.8723 | 0.9217 |
MCF 10A | Linsitinib | 10 | uM | LJP5 | 1 | O19 | 72 | hr | 962 | 8420 | 10714 | 0.7859 | 0.8661 |
MCF 10A | Linsitinib | 10 | uM | LJP5 | 2 | O19 | 72 | hr | 962 | 8730 | 10507 | 0.8308 | 0.8954 |
MCF 10A | Linsitinib | 10 | uM | LJP5 | 3 | O19 | 72 | hr | 962 | 8689 | 10315 | 0.8424 | 0.9022 |
MCF 10A | Ruxolitinib | 0.04 | uM | LJP5 | 1 | O18 | 72 | hr | 962 | 10454 | 10714 | 0.9757 | 0.9859 |
MCF 10A | Ruxolitinib | 0.04 | uM | LJP5 | 2 | O18 | 72 | hr | 962 | 10359 | 10507 | 0.9858 | 0.9917 |
MCF 10A | Ruxolitinib | 0.04 | uM | LJP5 | 3 | O18 | 72 | hr | 962 | 10117 | 10315 | 0.9808 | 0.9887 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 1 | O17 | 72 | hr | 962 | 10485 | 10714 | 0.9786 | 0.9876 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 2 | O17 | 72 | hr | 962 | 10215 | 10507 | 0.9721 | 0.9837 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 3 | O17 | 72 | hr | 962 | 10198 | 10315 | 0.9886 | 0.9933 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 1 | O16 | 72 | hr | 962 | 10247 | 10714 | 0.9564 | 0.9745 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 2 | O16 | 72 | hr | 962 | 10230 | 10507 | 0.9736 | 0.9845 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 3 | O16 | 72 | hr | 962 | 10026 | 10315 | 0.9720 | 0.9835 |
MCF 10A | Ruxolitinib | 1.11 | uM | LJP5 | 1 | O15 | 72 | hr | 962 | 9803 | 10714 | 0.9150 | 0.9495 |
MCF 10A | Ruxolitinib | 1.11 | uM | LJP5 | 2 | O15 | 72 | hr | 962 | 10048 | 10507 | 0.9562 | 0.9742 |
MCF 10A | Ruxolitinib | 1.11 | uM | LJP5 | 3 | O15 | 72 | hr | 962 | 9810 | 10315 | 0.9510 | 0.9709 |
MCF 10A | Ruxolitinib | 3.33 | uM | LJP5 | 1 | O14 | 72 | hr | 962 | 9377 | 10714 | 0.8752 | 0.9248 |
MCF 10A | Ruxolitinib | 3.33 | uM | LJP5 | 2 | O14 | 72 | hr | 962 | 10073 | 10507 | 0.9586 | 0.9756 |
MCF 10A | Ruxolitinib | 3.33 | uM | LJP5 | 3 | O14 | 72 | hr | 962 | 9571 | 10315 | 0.9279 | 0.9567 |